Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

Data demonstrate colon tissue PDE4/cAMP pathway modulation and sustained active metabolite exposure above IC90 across the dosing ...

New therapy for hard-to-treat inflammatory bowel disease shows promise

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

Women With Ulcerative Colitis Are More Likely to Be Misdiagnosed — Here Are the Signs to Look Out For

At least 2.4 million Americans have IBD. So why is it still so hard for women to get an accurate diagnosis?
AOL

Women With Ulcerative Colitis Are More Likely to Be Misdiagnosed — Here Are the Signs to Look Out For

Not long after giving birth to her son in 2021, Alex Marino started noticing changes to her digestion. She’d always had IBS, but she started going to the bathroom so often even her husband noticed a ...

A new map for inflammatory bowel disease: Human DNA in stool reveals disease activity

Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...

How Have Food Freedom, Not Food Fear, with an IBD Diagnosis

For millions with IBD, eating can be complicated. But these empowering, expert-backed tips help bring confidence and control ...

This Vitamin May Help “Retrain” The Immune System In Gut Inflammation

IBD is an immune condition. Instead of peacefully coexisting with gut microbes, the immune system becomes overly reactive, ...

Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week

KT-579 demonstrated activity comparable or superior to approved and clinically active therapies in preclinical IBD modelsKT-579 Phase 1 healthy ...
Clinical Advisor

Microscopic Colitis: An Unseen Cause of Chronic Diarrhea

A review of microscopic colitis, a chronic, intermittent inflammatory bowel disease that predominantly affects older women and typically presents with frequent watery, non-bloody stools.

Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week® 2026

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular, inflammatory, and fibrotic diseases, is presenting new translational data on its oral ...